European Commission grants authorization in adults and children 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment -- BOSTON, May 01, 2026 (GLOBE ...

Eli Lilly and Company (NYSE:LLY) executives said the drugmaker started 2026 with “a strong start,” pointing to sharp first-quarter revenue growth, continued demand for its incretin medicines, a newly ...

Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...

Nitinotes Ltd., a medical technology company with the first CE-marked automated suturing system designed for endoscopic sleeve ...

Allurion Technologies, Inc. (OTCID: ALUR), a pioneer in metabolically healthy weight loss, today announced the successful commercial treatment of its first patients in the United States—an inflection ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per GlobalData.

Camilla Sylvest will bring deep commercial expertise to the Board at a critical stage, as Zealand Pharma advances towards establishing its commercial footprint   The final decision to elect Camilla ...

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Torie Bosch: Whether it’s Ambien or Wegovy, ivermectin or fluoride, every drug in your medicine cabinet or advertised on TV ...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...